The PCOS Name Change & Guidelines
Helena is here to talk about the new PCOS guidelines and the name change. We talked about her diagnosis and the complexity of it.
www.thefertilitypodcast.comHere’s what I can share right now about Helena Teede and PCOS announcements, based on the latest publicly available reporting up to mid-2026.
Summary of the latest notable development: A widely reported update in May 2026 stated that the PCOS community has been discussing renaming PCOS to a broader term (reported in some outlets as PMOS/PMOS-related terminology) to better reflect the condition and reduce diagnostic delays. This initiative builds on Teede’s long-running work leading international PCOS guidelines and her advocacy for clearer language around the syndrome. This development appears in multiple outlets dating May 11, 2026, and references a Lancet publication and Prague announcement. The same theme—rebranding PCOS to a more accurate term—has been part of Teede’s recent public-facing work, including guideline development and global outreach.[1][2][7][9]
Context on the initiative: Teede has led international efforts to standardize PCOS guidelines and to reframe the conversation around the condition, emphasizing holistic management and the psychosocial aspects, not just ovarian features. Recent discussions emphasize moving away from cyst-focused language toward a broader understanding of PCOS as a metabolic, cardiovascular, and reproductive health syndrome.[7][1]
Related background: Teede’s leadership in the 2018 and 2023 International Evidence-Based Guidelines for PCOS and her broader influence on PCOS education and patient resources (e.g., ASK PCOS app) underpin these naming discussions and guideline updates.[9][1]
Public reception and impact: Reports note that changing the name is intended to improve patient understanding and reduce stigma, while the condition itself remains the same in medical terms; the change affects terminology and framing rather than the underlying biology of PCOS.[2]
Would you like me to pull the most current primary sources (e.g., Lancet articles, Prague announcements, or Monash/PCOS guideline pages) and summarize them in a concise timeline with direct quotes? I can compile a brief, cited timeline and include a short explainer of what the name change means for patients and clinicians.
Helena is here to talk about the new PCOS guidelines and the name change. We talked about her diagnosis and the complexity of it.
www.thefertilitypodcast.comPodcast Episode · The Fertility Podcast · 15 January 2024 · 46min
podcasts.apple.comTwo of members of the team at Monash Health have been recognised this week in the Queen’s Birthday 2021 Honours List. Both Professor Helena Teede and Professor Beverley Vollenhoven received the Member of the Order of Australia (AM) award. Monash Health extends its congratulations to Helena and Beverley for these well-deserved honours.
monashhealth.orgpmos is the new name for polycystic ovary syndrome after a 14-year global consultation led by Helena Teede. The change, published in the Lancet and announced in Prague on Tuesday, is meant to replace a label that has confused patients and doctors for decades.For people who have been told they have P…
www.el-balad.comMost experts and those experiencing the potentially debilitating features of Polycystic Ovary Syndrome (PCOS), which affects one in eight women, want greater awareness and a name change to improve care and outcomes.
www.news-medical.net